No current evidence supporting risk of using Ibuprofen in patients with COVID-19
- PMID: 32506743
- PMCID: PMC7300561
- DOI: 10.1111/ijcp.13576
No current evidence supporting risk of using Ibuprofen in patients with COVID-19
Conflict of interest statement
None.
Comment on
-
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11. Lancet Respir Med. 2020. PMID: 32171062 Free PMC article. No abstract available.
Similar articles
-
COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence?Am J Ther. 2020 Jul/Aug;27(4):e400-e402. doi: 10.1097/MJT.0000000000001196. Am J Ther. 2020. PMID: 32366740 Free PMC article.
-
NSAIDs for analgesia in the era of COVID-19.Reg Anesth Pain Med. 2020 Sep;45(9):677-678. doi: 10.1136/rapm-2020-101584. Epub 2020 Jun 3. Reg Anesth Pain Med. 2020. PMID: 32499385 Free PMC article.
-
Does Ibuprofen Worsen COVID-19?Drug Saf. 2020 Jul;43(7):611-614. doi: 10.1007/s40264-020-00953-0. Drug Saf. 2020. PMID: 32529474 Free PMC article. No abstract available.
-
Diabetes begünstigt Nierenversagen bei COVID-19-Patienten : Corona-Pandemie -- Autor: E. Fritschka.MMW Fortschr Med. 2020 Oct;162(18):31. doi: 10.1007/s15006-020-4481-x. MMW Fortschr Med. 2020. PMID: 33074500 Free PMC article. Review. German. No abstract available.
-
A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality.Inflammopharmacology. 2020 Oct;28(5):1141-1152. doi: 10.1007/s10787-020-00745-z. Epub 2020 Aug 14. Inflammopharmacology. 2020. PMID: 32797326 Free PMC article. Review.
Cited by
-
COVID-19 Management in the Pediatric Age: Consensus Document of the COVID-19 Working Group in Paediatrics of the Emilia-Romagna Region (RE-CO-Ped), Italy.Int J Environ Res Public Health. 2021 Apr 8;18(8):3919. doi: 10.3390/ijerph18083919. Int J Environ Res Public Health. 2021. PMID: 33917940 Free PMC article. Review.
-
A computational approach to aid clinicians in selecting anti-viral drugs for COVID-19 trials.Sci Rep. 2021 Apr 27;11(1):9047. doi: 10.1038/s41598-021-88153-3. Sci Rep. 2021. PMID: 33907209 Free PMC article.
-
Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review.J Clin Med. 2020 Dec 12;9(12):4021. doi: 10.3390/jcm9124021. J Clin Med. 2020. PMID: 33322733 Free PMC article. Review.
-
Clinical Management of Hypertension, Inflammation and Thrombosis in Hospitalized COVID-19 Patients: Impact on Survival and Concerns.J Clin Med. 2021 Mar 4;10(5):1073. doi: 10.3390/jcm10051073. J Clin Med. 2021. PMID: 33806709 Free PMC article.
-
Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?Front Pharmacol. 2020 Oct 7;11:579944. doi: 10.3389/fphar.2020.579944. eCollection 2020. Front Pharmacol. 2020. PMID: 33117175 Free PMC article.
References
-
- Krenke K, Krawiec M, Kraj G, Peradzynska J, Krauze A, Kulus M. Risk factors for local complications in children with community‐acquired pneumonia. Clin Respir J. 2018;12:253‐261. - PubMed
-
- François P, Desrumaux A, Cans C, Pin I, Pavese P, Labarère J. Prevalence and risk factors of suppurative complications in children with pneumonia. Acta Paediatr. 2010;99:861‐866. - PubMed
-
- Qiao W, Wang C, Chen B, et al. Ibuprofen attenuates cardiac fibrosis in streptozotocin‐induced diabetic rats. Cardiology. 2015;131:97‐106. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical